Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Toxic leukoencephalopathy.

C M Filley1

  • 1Department of Neurology, University of Colorado School of Medicine, Denver, USA.

Clinical Neuropharmacology
|October 12, 1999
PubMed
Summary
This summary is machine-generated.

Toxic leukoencephalopathy affects brain white matter due to various toxins. Magnetic resonance imaging aids early detection, and while pathogenesis is unclear, prevention is key, offering potential for improved outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal evaluation of diffusion tensor imaging and cognition in systemic lupus erythematosus.

Lupus·2018
Same author

Functional Magnetic Resonance Imaging of Working Memory and Executive Dysfunction in Systemic Lupus Erythematosus and Antiphospholipid Antibody-Positive Patients.

Arthritis care & research·2016
Same author

Toward an optimal "antiplatelet" dose of aspirin: Preliminary observations.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2015
Same author

Site differences in mild cognitive dysfunction (MCD) among patients with systemic lupus erythematosus (SLE).

Lupus·2012
Same author

Immune function and brain abnormalities in patients with systemic lupus erythematosus without overt neuropsychiatric manifestations.

Lupus·2011
Same author

Memory impairment associated with neurometabolic abnormalities of the hippocampus in patients with non-neuropsychiatric systemic lupus erythematosus.

Lupus·2011
Same journal

Characterization of Propranolol Use and Outcomes in Traumatic Brain Injury at a Level I Trauma Center.

Clinical neuropharmacology·2026
Same journal

Review of Medications That Reduce Neurological Deficits in Patients With Traumatic Brain Injury.

Clinical neuropharmacology·2026
Same journal

Pre-Existing Peak-Dose Dyskinesia and Light Body Weight as Predictors of Ropinirole Patch Dose Modification in Parkinson Disease: A Multicenter Retrospective Study.

Clinical neuropharmacology·2026
Same journal

A Double-blind, Placebo-controlled Study of Lumateperone in the Treatment of Borderline Personality Disorder.

Clinical neuropharmacology·2026
Same journal

Yesterday Once More: Revisiting Catatonia in an Elderly Stroke Patient.

Clinical neuropharmacology·2026
Same journal

Overlapping Hyperosmolar Therapy in Patients With Elevated and Refractory Intracranial Pressure.

Clinical neuropharmacology·2026
See all related articles

Area of Science:

  • Neuroscience
  • Toxicology
  • Radiology

Background:

  • White matter is susceptible to diverse toxins, leading to increasingly recognized leukoencephalopathy.
  • Magnetic resonance imaging (MRI) enhances detection of subtle, early toxic effects on white matter.
  • Neuropathologic features of leukoencephalopathy are becoming better understood.

Purpose of the Study:

  • To review the emerging clinical disorder of toxic leukoencephalopathy.
  • To discuss the role of neuroimaging in detecting white matter injury.
  • To highlight the neurobehavioral manifestations and potential outcomes of toxic white matter damage.

Main Methods:

  • Review of existing literature on toxic leukoencephalopathy.
  • Discussion of neuroimaging findings, particularly MRI, in white matter injury.

Related Experiment Videos

  • Analysis of neuropathologic features and clinical presentations.

    • Main Results:

    • Toxic injury affects white matter from various sources including irradiation, chemotherapy, drugs, and environmental agents.
    • Leukoencephalopathy can be reversible or progressive, associated with significant neurobehavioral changes, including dementia.
    • Axon sparing, despite myelin damage, may contribute to a favorable prognosis in some cases.

    Conclusions:

    • Toxic leukoencephalopathy is an emerging clinical concern with varied patient outcomes.
    • Prevention through toxin avoidance is the primary treatment strategy.
    • Further understanding of white matter's role in cognition and emotion is crucial for improving patient care.